BPC 157 Peptide Therapy Doctors Supplement Store The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn BPC 157 Peptide Foundry Premium Research Peptides